StonvexLoading…
StonvexCore line items from AMBO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $9.47M | $9.39M |
Operating Income | $112.00K | $-722.00K |
Net Income | $1.36M | $309.00K |
EPS (Diluted) | $0.02 | $0.01 |
Total Assets | $20.80M | $17.37M |
Total Liabilities | $12.55M | $10.63M |
Cash & Equivalents | $831.00K | $1.12M |
Free Cash Flow OCF − CapEx | $-463.00K | $435.00K |
Shares Outstanding | 57.64M | 57.13M |